Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

Blood Cancer J. 2016 Sep 30;6(9):e477. doi: 10.1038/bcj.2016.88.

Authors

A Kawajiri¹, D Maruyama¹, A M Maeshima², J Nomoto¹, S Makita¹, H Kitahara¹, K-I Miyamoto¹, S Fukuhara¹, T Suzuki¹, W Munakata¹, K Tajima¹, J Itami³, H Taniguchi², Y Kobayashi¹, K Tobinai¹

Affiliations

¹ Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
² Department of Pathology and Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan.
³ Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.

No abstract available